Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL.
暂无分享，去创建一个
M. Kersten | G. Salles | Iulian Pruteanu-Malinici | U. Jäger | C. Tam | S. Schuster | K. Mueller | E. Waller | P. Borchmann | S. Jaglowski | L. Pacaud | R. Awasthi | J. Chu | Ö. Anak | R. Maziarz | A. Chakraborty | S. R. Foley | N. Wagner-Johnston | Edward R. Waldron | K. van Besien | Christopher del Corral | Irina Gershgorin